A new drug candidate could help treat measles, croup and other related viral diseases that cause contagious and life-threatening respiratory infections, Georgia State University researchers say.
The new antiviral drug candidate, known as GHP-88310, is the “most promising inhibitor of this virus family that we have encountered in years of research,” Carolin Lieber, a senior postdoctoral fellow in the school’s Center for Translational Antiviral Research, explained in a statement alongside their related study.
